Investigating an mRNA CAR T-cell Therapy, Known as Descartes-08, as a Potential Approach to Treat Myasthenia Gravis
Trial details
- Registry ID
- NCT06799247
- Phase
- Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Investigating an mRNA CAR T-cell Therapy, Known as Descartes-08, as a Potential Approach to Treat Myasthenia GravisNCT06799247 | Cartesian Therapeutics | Phase 3 | Active not recruiting | 2026-12-30Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |